144 related articles for article (PubMed ID: 15226172)
21. Diagnosis of early relapse in ovarian cancer using serum proteomic profiling.
Oh JH; Gao J; Nandi A; Gurnani P; Knowles L; Schorge J
Genome Inform; 2005; 16(2):195-204. PubMed ID: 16901102
[TBL] [Abstract][Full Text] [Related]
22. Serum peptide/protein profiling by mass spectrometry provides diagnostic information independently of CA125 in women with an ovarian tumor.
Callesen AK; Madsen JS; Iachina M; Vach W; Kruse TA; Jensen ON; Mogensen O
Cancer Biomark; 2010; 6(2):73-82. PubMed ID: 20571233
[TBL] [Abstract][Full Text] [Related]
23. Biomarker discovery for ovarian cancer using SELDI-TOF-MS.
Zhang H; Kong B; Qu X; Jia L; Deng B; Yang Q
Gynecol Oncol; 2006 Jul; 102(1):61-6. PubMed ID: 16403569
[TBL] [Abstract][Full Text] [Related]
24. Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection.
Hong YJ; Wang XD; Shen D; Zeng S
Acta Pharmacol Sin; 2008 Oct; 29(10):1240-6. PubMed ID: 18817630
[TBL] [Abstract][Full Text] [Related]
25. [Serum proteome profiling for ovarion cancer diagnosis using ClinProt magnetic bead technique and MALDI-TOF-mass-spectrometry].
Ziganshin RKh; Alekseev DG; Arapidi GP; Ivanov VT; Moshkovskiĭ SA; Govorun VM
Biomed Khim; 2008; 54(4):408-19. PubMed ID: 18988457
[TBL] [Abstract][Full Text] [Related]
26. Acid hydrolysis followed by matrix-assisted laser desorption/ionization mass spectrometry for the rapid diagnosis of serum protein biomarkers in patients with major depression.
Lo LH; Huang TL; Shiea J
Rapid Commun Mass Spectrom; 2009 Mar; 23(5):589-98. PubMed ID: 19165777
[TBL] [Abstract][Full Text] [Related]
27. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
[TBL] [Abstract][Full Text] [Related]
28. Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post-translational modifications.
Liu C; Shea N; Rucker S; Harvey L; Russo P; Saul R; Lopez MF; Mikulskis A; Kuzdzal S; Golenko E; Fishman D; Vonderheid E; Booher S; Cowen EW; Hwang ST; Whiteley GR
Proteomics; 2007 Nov; 7(22):4045-52. PubMed ID: 17952875
[TBL] [Abstract][Full Text] [Related]
29. A novel approach for clustering proteomics data using Bayesian fast Fourier transform.
Bensmail H; Golek J; Moody MM; Semmes JO; Haoudi A
Bioinformatics; 2005 May; 21(10):2210-24. PubMed ID: 15769836
[TBL] [Abstract][Full Text] [Related]
30. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
[TBL] [Abstract][Full Text] [Related]
31. Support vector machine approach to separate control and breast cancer serum samples.
Pham TV; van de Wiel MA; Jimenez CR
Stat Appl Genet Mol Biol; 2008; 7(2):Article11. PubMed ID: 18312216
[TBL] [Abstract][Full Text] [Related]
32. [Detecting biomarkers from serum in nephroblastoma patients with support vector machine].
Wang JX; Zhang J; Liu QL; Wang L; Fan YZ; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2982-5. PubMed ID: 17288811
[TBL] [Abstract][Full Text] [Related]
33. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
[TBL] [Abstract][Full Text] [Related]
34. MALDI imaging mass spectrometry in ovarian cancer for tracking, identifying, and validating biomarkers.
El Ayed M; Bonnel D; Longuespée R; Castelier C; Franck J; Vergara D; Desmons A; Tasiemski A; Kenani A; Vinatier D; Day R; Fournier I; Salzet M
Med Sci Monit; 2010 Aug; 16(8):BR233-45. PubMed ID: 20671603
[TBL] [Abstract][Full Text] [Related]
35. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer.
Petricoin EF; Liotta LA
Curr Opin Biotechnol; 2004 Feb; 15(1):24-30. PubMed ID: 15102462
[TBL] [Abstract][Full Text] [Related]
36. Method for differential detection and identification of components in protein mixtures analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Ossipova E; Nord LI; Kenne L; Eriksson J
Rapid Commun Mass Spectrom; 2004; 18(18):2053-8. PubMed ID: 15378717
[TBL] [Abstract][Full Text] [Related]
37. Proteomic studies of early-stage and advanced ovarian cancer patients.
Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
[TBL] [Abstract][Full Text] [Related]
38. Finding regions of significance in SELDI measurements for identifying protein biomarkers.
Tan CS; Ploner A; Quandt A; Lehtiö J; Pawitan Y
Bioinformatics; 2006 Jun; 22(12):1515-23. PubMed ID: 16567365
[TBL] [Abstract][Full Text] [Related]
39. An extended Markov blanket approach to proteomic biomarker detection from high-resolution mass spectrometry data.
Oh JH; Gurnani P; Schorge J; Rosenblatt KP; Gao JX
IEEE Trans Inf Technol Biomed; 2009 Mar; 13(2):195-206. PubMed ID: 19126475
[TBL] [Abstract][Full Text] [Related]
40. Can crude oils be distinguished by different component distribution obtained by laser desorption ionization mass spectrometry and evaluated by chemometrics?
Smaniotto A; Montanari L; Flego C; Rizzi A; Ragazzi E; Seraglia R; Traldi P
Rapid Commun Mass Spectrom; 2008 May; 22(10):1597-606. PubMed ID: 18433081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
